Annual Financial Report

RNS Number : 2121K

Alpha Growth PLC

31 December 2020

 

Alpha Growth plc

("Alpha", or the "Company")

 Publication of the 2020 Annual Report

Alpha Growth Plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class will publish on the Company's website its Annual Report for the year ended 31 August 2020 (the '2020 Annual Report'). The 2020 Annual Report is available at www.algwplc.com .

In compliance with Listing Rule 9.6.1 of the UK Financial Conduct Authority ('FCA'), the 2020 Annual Report will in due course be available for inspection at www.morningstar.co.uk/uk/NSM .

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth Plc	[phone]
Gobind Sahney, Executive Chairman	[e-mail]
Pello Capital Limited	[phone]
Mark Treharne	[e-mail]

About Alpha Growth Plc

Specialist in Longevity Assets

Alpha Growth Plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

SLS Assets and Non-correlation

A SLS refers to the sale of an existing life insurance policy to a third party for a cash payment. Such a payment will be in excess of the policy's surrender value, but less than its face value. After the sale, the purchaser becomes the policy's beneficiary and assumes payment of its premiums. There are many reasons why policy holders may choose to sell their life insurance policies and sales are usually only undertaken when the insured person doesn't have a known life-threatening illness. The SLS provides individuals with policies the option to realise value from an asset under a regulated transaction. As a longevity asset, the SLS is non-correlated to the real estate, equity capital and commodity markets.  Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages SLS Assets that originate in the USA where the SLS market is highly regulated.

ENDS

 

END

 

 

ACSEAEAFDAEEFEA